ELAB NASDAQ
PMGC Holdings Inc.
1W: -26.5%
1M: -34.0%
3M: -74.9%
YTD: -99.8%
1Y: -99.9%
$3.36
+0.14 (+4.19%)
Weekly Expected Move ±14.5%
$2
$3
$3
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.5M
52W Range2.585-2671.2
Volume20,600
Avg Volume220,931
Beta-0.25
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOGraydon Bensler
Employees33
SectorHealthcare
IndustryBiotechnology
IPO Date2023-11-21
Websitepmgcholdings.com
120 Newport Center Drive
Newport Beach, CA 92660
US
Newport Beach, CA 92660
US
866 445 4886
About PMGC Holdings Inc.
PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists. Beyond its core operations, the company also engages in medical scientific research and development and manages various investment firms. Formerly known as Elevai Labs, Inc., the organization adopted its current name, PMGC Holdings Inc., in December 2024. Established in 2020, PMGC Holdings Inc. maintains its headquarters in Newport Beach, California.
Latest News
NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications
PMGC Holdings Terminates Previously Announced Acquisition LOI Following Due Diligence Review; Reaffirms Disciplined M&A Strategy and Expands Investment Across Aerospace & Defense Manufacturing Portfolio
PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q2 2026 Results and Files Form 10-Q; Total Assets Reach $36.6 Million, Up 184% from Year-End 2025 and 290% Year-over-Year, as Quarterly Revenue Nearly Doubles Sequentially
PMGC Holdings Inc. Announces Merger of AGA Precision Systems into A&B Aerospace
NorthStrive Biosciences Announces Positive Results from Phase III of AI-Driven Drug Discovery Program with Yuva Biosciences
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Parry Jeffrey | A-Award | 75,046 | $1.77 | 2026-06-01 |
| Braeden Lichti | A-Award | 450,277 | $1.77 | 2026-06-01 |
| Daley Juliana | A-Award | 75,046 | $1.77 | 2026-06-01 |
| Kovalyov George | A-Award | 75,046 | $1.77 | 2026-06-01 |
| Bensler Graydon | A-Award | 3,036,437 | — | 2025-03-26 |